Safety and pharmacokinetics of DS-6051b in Japanese patients with non-small cell lung cancer harboring ROS1 fusions: a phase I study

por Fujiwara, Yutaka, Takeda, Masayuki, Yamamoto, Noboru, Nakagawa, Kazuhiko, Nosaki, Kaname, Toyozawa, Ryo, Abe, Chihiro, Shiga, Ryota, Nakamaru, Kenji, Seto, Takashi
Publicado 2018

Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials

por Yokota, Tomoya, Bendell, Johanna, LoRusso, Patricia, Tsushima, Takahiro, Desai, Ved, Kenmotsu, Hirotsugu, Watanabe, Junichiro, Ono, Akira, Murugesan, Bhavani, Silva, Joseph, Naito, Tateaki, Greenberg, Jonathan, Kumar, Prasanna, Wang, Yibin, Jikoh, Takahiro, Shiga, Ryota, Hyman, David M., Ho, Alan Loh, Spriggs, David R., Schwartz, Gary K., Gounder, Mrinal M.
Publicado 2018